Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 22, 2018
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) today announced it has closed its previously announced $50 million registered direct ...
May 22, 2018
Zosano Appoints Steven A. Elms to Board of Directors
FREMONT, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic ...
May 22, 2018
Prometic presents new clinical data on PBI-4050 for the treatment of idiopathic pulmonary fibrosis
LAVAL, QC , May 22, 2018 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced an oral presentation of new clinical data assessing ...
May 22, 2018
Paratek Presents New Analysis Highlighting Efficacy of Omadacycline in Treating Community-Acquired Bacterial Pneumonia by Measures of Disease Severity
BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
May 22, 2018
Pfenex Announces Offering of Common Stock
SAN DIEGO, May 22, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression ...
May 21, 2018
UroGen Pharma Announces Positive Interim Results from Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
RA’ANANA, Israel and NEW YORK, May 21, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
May 21, 2018
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (Arcturus or the Company) (ARCT), an RNA medicines company, today announced that it will ...
May 21, 2018
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
NEW YORK, May 21, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, ...
May 21, 2018
Arrowhead Pharmaceuticals Presents New Preclinical Data on ARO-ENaC for Treatment of Cystic Fibrosis
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (ARWR) today announced the presentation of new preclinical data on ARO-ENaC, formerly referred to as ARO-Lung1, for the treatment of ...
May 21, 2018
Arena Pharmaceuticals Announces Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference
SAN DIEGO, May 21, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that data from a post-hoc analysis of the 22-week Phase 2 clinical study for ...
May 21, 2018
CytoSorbents to Present at the 19th Annual B. Riley FBR Investor Conference
MONMOUTH JUNCTION, N.J., May 21, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation ...
May 16, 2018
ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections
RAMSEY, N.J. and BOCA RATON, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) today announced that the United ...
May 16, 2018
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
REDWOOD CITY, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
May 16, 2018
PolarityTE Announces Rich Haerle as the New Vice President of Investor Relations and Corporate Strategy
SALT LAKE CITY, May 16, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) today announced the appointment of Rich Haerle as Vice President of Investor Relations ...
May 16, 2018
Progeria Research Foundation Announces Collaboration and Supply Agreement with Eiger BioPharmaceuticals
PEABODY, Mass., May 16, 2018 /PRNewswire/ -- The Progeria Research Foundation (PRF) announced a collaboration and supply agreement with Eiger BioPharmaceuticals for the development and pursuit ...
May 16, 2018
Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)
PALO ALTO, Calif., May 16, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
May 16, 2018
BioLife Solutions Makes Investment in SAVSU Technologies to Support Growth and Capture Additional Regenerative Medicine Cold Chain Opportunities
BOTHELL, Wash., May 16, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical-grade biopreservation media, ("BioLife" or the "Company"), ...
May 16, 2018
Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease at the American Thoracic Society 114th International Conference
WARREN, N.J., May 16, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will present ...
May 16, 2018
Albireo Enrolls First Patient in Phase 3 PFIC Trial of A4250
BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
May 16, 2018
Zealand Pharma - Interim report for the first quarter of 2018
Copenhagen, May 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), the Copenhagen-based company focused on discovery, design and development ...
Page 71 of 149